Literature DB >> 8751810

[A case of AFP (alpha-fetoprotein) producing gastric cancer successfully treated with FEP (5-FU, Epirubicin, cisplatin) therapy by continuous venous daily infusion of 5-FU and low-dose CDDP].

K Hoshino1, H Kawaguchi, H Unate, K Nitta, H Fukui, M Ikeda, S Tsujitani.   

Abstract

We reported our experience with a case of AFP producing gastric cancer with liver metastasis successfully treated with FEP therapy by continuous daily venous infusion of 5-FU and low-dose CDDP. A 59-year-old male was diagnosed with liver metastasis 2 months after partial gastrectomy of gastric cancer and then admitted. The patient received five courses of 24-hour continuous infusion of CDDP (5 mg/day, on day 1, 2, 3, 4, 5) and 5-FU (250 mg/day, on day 1, 3, 5) and bolus infusion of Epirubicin (10 mg/day, on day 3). No remarkable side effect was encountered. Complete response at the liver metastasis was observed by CT scan. Serum AFP level was down from 614 ng/ml to the normal range of 0.5 ng/ml after the therapy. The patient has been well for 10 months with complete remission.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8751810

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Expression of AFP and STAT3 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in AFP-producing gastric cancer cells.

Authors:  Yanfei Jia; Dezhi Liu; Dongjie Xiao; Xiaoli Ma; Shuyi Han; Yan Zheng; Shanhui Sun; Maoxiu Zhang; Hongmei Gao; Xia Cui; Yunshan Wang
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

2.  Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases.

Authors:  Hiromitsu Takeyama; Hirozumi Sawai; Takehiro Wakasugi; Hiroki Takahashi; Yoichi Matsuo; Nobuo Ochi; Akira Yasuda; Mikinori Sato; Yuji Okada; Hitoshi Funahashi; Yoshimi Akamo; Tadao Manabe
Journal:  World J Surg Oncol       Date:  2007-07-16       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.